QTc: FDA proposes labeling for heart drugs with heart rhythm risk

Regulatory News

Regulatory NewsFerdous Al-Faruque

Advertising, Promotion and LabelingClinical TrialsComplianceNorth AmericaPharmaceuticalsPreclinical studyProduct LifecycleRegulatory Intelligence/PolicyResearch, Design and Development